Eli Manning: NY Giants great joins Make-A-Wish for late toddler s wish northjersey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from northjersey.com Daily Mail and Mail on Sunday newspapers.
Potential drug treatment for fatal childhood cancer
By IANS |
Published on
Sun, Feb 14 2021 19:27 IST |
0 Views
High-Fibre Diet May Lower Colon Cancer Risk. Image Source: IANS News
Sydney, Feb 14 : A team of researchers have identified a potential new drug treatment for a fatal childhood cancer Diffuse Intrinsic Pontine Glioma (DIPG).
The study, published in the journal Nature Communications, reveals a potential drug combination that in animal studies and in world-first 3D models of the tumour is spectacularly effective in eradicating the cancer cells, according to the researchers
In pre-clinical testing in mouse models, the researchers found that the promising drug combination led to survival in two-thirds of the mice and that the drug combination completely halted the growth of these highly aggressive tumours in these mice.
Researchers find potential new treatment for fatal childhood brain cancer ANI | Updated: Feb 14, 2021 19:22 IST
Washington [US], February 14 (ANI): Every year around 20 Australian children die from the incurable brain tumour, Diffuse Intrinsic Pontine Glioma (DIPG). The average age of diagnosis for DIPG is just seven years. There are no effective treatments, and almost all children die from the disease, usually within one year of diagnosis.
A paper published in the journal Nature Communications, reveals a potential revolutionary drug combination that in animal studies and in world-first 3D models of the tumour is spectacularly effective in eradicating the cancer cells, according to lead researcher and paediatric oncologist Associate Professor c from the Children s Cancer Institute and Sydney Children s Hospital.
Researchers Identify New Drug for Treating Childhood Cancer by Angela Mohan on February 12, 2021 at 4:02 PM
New drug combination is found to be effective in eradicating the cancer cells in incurable brain tumour named Diffuse Intrinsic Pontine Glioma (DIPG), as per the paper published in the prestigious journal,
Nature Communications by paediatric oncologist Associate Professor David Ziegler, from the Children s Cancer Institute and Sydney Children s Hospital.
In pre-clinical testing in mouse models, the researchers found that the promising drug combination led to survival in two thirds of the mice and that the drug combination completely halted growth of these highly aggressive tumours in these mice.
How long until cloud becomes the preferred environment to run HPC workloads?
The high-performance computing market is growing, but enterprises that have already made large investments in on-premise HPC will need to weigh up whether a move to the cloud would be worth their while
Share this item with your network: By Published: 27 Jan 2021
Enterprise spending on high-performance computing (HPC) has skyrocketed over the past decade. According to Intersect360 Research, a 10-year growth streak from 2009 to 2019 culminated in global HPC market revenue reaching $39bn in 2019.
The Covid-19 pandemic is expected to have stunted the market’s growth somewhat, with projections suggesting spending will have contracted by 3.7% once the final figures for 2020 are in.